Correlation Between LAVA Medtech and Pyrophyte Acquisition

Can any of the company-specific risk be diversified away by investing in both LAVA Medtech and Pyrophyte Acquisition at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining LAVA Medtech and Pyrophyte Acquisition into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between LAVA Medtech Acquisition and Pyrophyte Acquisition Corp, you can compare the effects of market volatilities on LAVA Medtech and Pyrophyte Acquisition and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in LAVA Medtech with a short position of Pyrophyte Acquisition. Check out your portfolio center. Please also check ongoing floating volatility patterns of LAVA Medtech and Pyrophyte Acquisition.

Diversification Opportunities for LAVA Medtech and Pyrophyte Acquisition

-0.44

Correlation Coefficient

LAVA Medtech  Pyrophyte Acquisition

Very good diversification

The 3 months correlation between LAVA and Pyrophyte is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding LAVA Medtech Acquisition and Pyrophyte Acquisition Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pyrophyte Acquisition and LAVA Medtech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on LAVA Medtech Acquisition are associated (or correlated) with Pyrophyte Acquisition. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pyrophyte Acquisition has no effect on the direction of LAVA Medtech i.e., LAVA Medtech and Pyrophyte Acquisition go up and down completely randomly.

Pair Corralation between LAVA Medtech and Pyrophyte Acquisition

Given the investment horizon of 90 days LAVA Medtech Acquisition is expected to generate 1.07 times more return on investment than Pyrophyte Acquisition. However, LAVA Medtech is 1.07 times more volatile than Pyrophyte Acquisition Corp. It trades about 0.17 of its potential returns per unit of risk. Pyrophyte Acquisition Corp is currently generating about 0.14 per unit of risk. If you would invest  1,019  in LAVA Medtech Acquisition on September 19, 2024 and sell it today you would earn a total of  25.00  from holding LAVA Medtech Acquisition or generate 2.45% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	18.99%
Values	Daily Returns

LAVA Medtech Acquisition  vs.  Pyrophyte Acquisition Corp

LAVA Medtech Acquisition

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days LAVA Medtech Acquisition has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, LAVA Medtech is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Pyrophyte Acquisition

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Pyrophyte Acquisition Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Pyrophyte Acquisition is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with LAVA Medtech and Pyrophyte Acquisition

The main advantage of trading using opposite LAVA Medtech and Pyrophyte Acquisition positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if LAVA Medtech position performs unexpectedly, Pyrophyte Acquisition can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pyrophyte Acquisition will offset losses from the drop in Pyrophyte Acquisition's long position.

The idea behind LAVA Medtech Acquisition and Pyrophyte Acquisition Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.